# Multi-center Clinical Study on Hemoperfusion of KHA80

> **NCT06233838** · NA · RECRUITING · sponsor: **First Affiliated Hospital of Fujian Medical University** · enrollment: 394 (estimated)

## Conditions studied

- Uremia
- Uremic Osteodystrophy
- Dialysis Related Complication

## Interventions

- **DEVICE:** KHA80 hemoperfusion treatment

## Key facts

- **NCT ID:** NCT06233838
- **Lead sponsor:** First Affiliated Hospital of Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-13
- **Primary completion:** 2026-02-28
- **Final completion:** 2027-05-31
- **Target enrollment:** 394 (ESTIMATED)
- **Last updated:** 2025-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06233838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06233838, "Multi-center Clinical Study on Hemoperfusion of KHA80". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06233838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*